VMD

Viemed Healthcare Inc.

Price

$8.94

return (12m)

28.63%

p/e

24.18

p/bv

2.40

DIVIDEND YIELD

0.00%

VMD price

Viemed Healthcare

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-24.87%

3 months

-7.17%

1 year

28.63%

2 years

22.30%

5 years

40.13%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals VMD

Valuation

P/E

24.18

Sector -2.19

Industry 1.21

P/BV

2.40

Sector 2.22

Industry 2.11

P/Revenue (PSR)

1.16

Sector 2.01

Industry 0.78

EV/EBITDA

27.51

Sector -17.81

Industry -25.30

EV/EBIT

68.39

Sector -26.72

Industry -18.04

P/EBITDA

6.53

Sector 0.36

Industry 0.18

P/EBIT

14.99

Sector -3.34

Industry 1.26

P/Total Assets

1.72

Sector 1.23

Industry 0.86

P/Net Current Assets

-81.67

Sector -27.35

Industry -12.37

P/Working Capital

57.63

Sector -4.54

Industry -49.48

EPS

0.38

Sector -0.87

Industry -0.55

BVPS

3.84

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

57.47%

Sector 43.36%

Industry 31.53%

EBITDA Margin

16.11%

Sector -323.65%

Industry -73.39%

EBIT Margin

6.48%

Sector -194.57%

Industry -11.94%

Operating Margin

8.12%

Sector -24.37%

Industry -9.87%

Net Profit Margins

4.80%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.38

Sector 0.12

Industry 0.22

Profitability

ROE

9.93%

Sector -33.82%

Industry -37.56%

ROA

7.10%

Sector -29.63%

Industry -17.56%

ROIC

8.76%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.13

Sector 1.84

Industry 1.14

Net Debt / EBITDA

-0.34

Sector -1.47

Industry -31.86

Net Debt / EBIT

-0.85

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.03

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.04

Sector 0.14

Industry 0.51

Equity/Assets

0.71

Sector 0.42

Industry 0.25

Liabilities/Assets

0.29

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

20.84%

Sector -

Industry -

5Y Earnings CAGR

9.68%

Sector -

Industry -

FAIR VALUE OF Viemed Healthcare ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$8.94

Fair Value

$5.73

Upside Return potential.

-35.91%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals VMD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
VMD Viemed Healthcare Inc.	$8.94	29.19%	0.00%	24.18	2.40	9.93%	4.80%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VMD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Viemed Healthcare

Viemed Healthcare Inc.

Average Investor10 user rating

4.0 (0 people)

United States

10 years

Founded: 2016

2018

Time since IPO - 8 years

418

Employees

Viemed Healthcare Inc. (United States) is listed on the Nasdaq and has a market capitalization of $350.36 million, with shareholders equity totaling $145.96 million.

The company employs approximately 418 people and operates in the Health sector, within the Health Services and Providers industry.

Over the past 12 months, Viemed Healthcare Inc. reported $301.60 million in revenue, generating net income of $14.49 million.

Key financial metrics include a P/E ratio of 24.18, a price-to-book (P/B) ratio of 2.40, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VMD.

Market cap

$350.36 million

Net worth

$145.96 million

$145,960,000.00

Assets

$204.22 million

$204,220,000.00

Total Shares Outstanding

38.00 million

38,000,000

Average Daily Trading Volume

$368.29 Thousand

$368,288.00

Sector

Health

Industry

Health Services and Providers

VMD

VMD revenue and profits

Financial Results VMD

DRAG THE FRAME TO SEE MORE DATA

VMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87